These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 20941387)

  • 1. Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood.
    Chatterjee MS; Denney WS; Jing H; Diamond SL
    PLoS Comput Biol; 2010 Sep; 6(9):. PubMed ID: 20941387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIIa-mediated tenase function on activated platelets under flow.
    Goel MS; Diamond SL
    J Thromb Haemost; 2004 Aug; 2(8):1402-10. PubMed ID: 15304047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation kinetics: high throughput method for real-time reaction monitoring.
    Lo K; Diamond SL
    Thromb Haemost; 2004 Oct; 92(4):874-82. PubMed ID: 15467920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.
    Hoffman M; Monroe DM; Oliver JA; Roberts HR
    Blood; 1995 Sep; 86(5):1794-801. PubMed ID: 7655009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin.
    Colace TV; Muthard RW; Diamond SL
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1466-76. PubMed ID: 22516070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood.
    Hansson KM; Nielsen S; Elg M; Deinum J
    J Thromb Haemost; 2014 Oct; 12(10):1678-86. PubMed ID: 25142753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble fibrin causes an acquired platelet glycoprotein VI signaling defect: implications for coagulopathy.
    Lee MY; Verni CC; Herbig BA; Diamond SL
    J Thromb Haemost; 2017 Dec; 15(12):2396-2407. PubMed ID: 28981200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases.
    Butenas S; van 't Veer C; Mann KG
    J Biol Chem; 1997 Aug; 272(34):21527-33. PubMed ID: 9261172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
    Kempton CL; Hoffman M; Roberts HR; Monroe DM
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):861-6. PubMed ID: 15653564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
    Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I
    Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow.
    Zhu S; Travers RJ; Morrissey JH; Diamond SL
    Blood; 2015 Sep; 126(12):1494-502. PubMed ID: 26136249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of coagulation factor XI by a casein kinase released by activated human platelets increases its susceptibility to activation by factor XIIa and thrombin.
    Ekdahl KN; Elgue G; Nilsson B
    Thromb Haemost; 1999 Oct; 82(4):1283-8. PubMed ID: 10544914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced model to predict thrombin and fibrin during thrombosis on collagen/tissue factor under venous flow: Roles of γ'-fibrin and factor XIa.
    Chen J; Diamond SL
    PLoS Comput Biol; 2019 Aug; 15(8):e1007266. PubMed ID: 31381558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on platelet function of a direct acting antagonist of coagulation factor Xa.
    Ringwala SM; Dibattiste PM; Schneider DJ
    J Thromb Thrombolysis; 2012 Oct; 34(3):291-6. PubMed ID: 22528328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation.
    Leiderman K; Chang WC; Ovanesov M; Fogelson AL
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2334-2345. PubMed ID: 27789475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
    Wong PC; Jiang X
    Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa.
    Baglia FA; Walsh PN
    J Biol Chem; 2000 Jul; 275(27):20514-9. PubMed ID: 10781579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.
    Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Roberts HR
    Thromb Haemost; 1998 Oct; 80(4):578-84. PubMed ID: 9798973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.